RxDoctor Payments Data

Kimberly Kirkup, NP

Psychiatric/Mental Health · Fairbanks, AKNPI 1639855844

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.8% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for psychiatric/mental health clinicians in AK, where the typical reported total is $371.

$379in general payments, 2019–2025

Across 17 payments — averaging $22.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$88
  • E.r. Squibb & Sons, L.L.C.$54
  • Alkermes, Inc.$47
  • Neurocrine Biosciences, Inc.$45
  • Otsuka America Pharmaceutical, Inc.$43
  • Sage Therapeutics, LLC$37
  • plus $63 from 3 others

What the payments were for

  • Food & beverage$35293%
  • Education$277%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$379 in reported general payments places this provider in the 50th percentile of 104 psychiatric/mental health providers in Alaska.

See all psychiatric/mental health providers in Alaska

Medicare billing

Part B allowed, 2024
$15,737
Medicare patients
27
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole17$305
Buspirone Hcl15$67
Clonidine Hcl11$29

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Fairbanks

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →